140 related articles for article (PubMed ID: 16050486)
1. Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions.
Turatti E; da Costa Neves A; de Magalhães MH; de Sousa SO
J Oral Sci; 2005 Jun; 47(2):71-6. PubMed ID: 16050486
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of c-Fos and c-Jun in human oral mucosa and in oral squamous cell carcinoma.
de Sousa SO; Mesquita RA; Pinto DS; Gutkind S
J Oral Pathol Med; 2002 Feb; 31(2):78-81. PubMed ID: 11896827
[TBL] [Abstract][Full Text] [Related]
3. Expression of p16 and CDK4 in oral premalignant lesions and oral squamous cell carcinomas: a semi-quantitative immunohistochemical study.
Chen Q; Luo G; Li B; Samaranayake LP
J Oral Pathol Med; 1999 Apr; 28(4):158-64. PubMed ID: 10235368
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
Mishra R; Das BR
Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297
[TBL] [Abstract][Full Text] [Related]
5. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
6. Correlation between c-Jun and human papillomavirus in oral premalignant and malignant lesions.
Acay RR; dos Santos E; de Sousa SO
Oral Oncol; 2008 Jul; 44(7):698-702. PubMed ID: 18061529
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
8. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
[TBL] [Abstract][Full Text] [Related]
9. [Bax protein expression in the carcinogenesis of human oral mucosa].
Zeng X; Chen Q; Li B; Tan N
Hua Xi Kou Qiang Yi Xue Za Zhi; 2000 Apr; 18(2):88-90. PubMed ID: 12539337
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Smad proteins, especially Smad7, in oral epithelial dysplasias.
Chen YK; Huang AH; Cheng PH; Yang SH; Lin LM
Clin Oral Investig; 2013 Apr; 17(3):921-32. PubMed ID: 22669485
[TBL] [Abstract][Full Text] [Related]
11. Image analysis of p53 and cyclin D1 expression in premalignant lesions of the oral mucosa.
Liu SC; Hu Y; Sauter ER; Clapper ML; Chen SY; Lanfranchi HE; Engstrom PF; Klein-Szanto AJ
Anal Quant Cytol Histol; 1999 Apr; 21(2):166-73. PubMed ID: 10560487
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclin D1 correlates with p27
Guan G; Bakr MM; Firth N; Love RM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Aug; 126(2):174-183. PubMed ID: 29550080
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of retinoic acid receptor beta (RARbeta) and the AP-1 transcription factor in normal, premalignant and malignant human laryngeal tissues.
Karamouzis MV; Sotiropoulou-Bonikou G; Vandoros G; Varakis I; Papavassiliou AG
Eur J Cancer; 2004 Mar; 40(5):761-73. PubMed ID: 15010078
[TBL] [Abstract][Full Text] [Related]
15. Differential Expression of c-fos Proto-Oncogene in Normal Oral Mucosa versus Squamous Cell Carcinoma.
Krishna A; Bhatt MLB; Singh V; Singh S; Gangwar PK; Singh US; Kumar V; Mehrotra D
Asian Pac J Cancer Prev; 2018 Mar; 19(3):867-874. PubMed ID: 29582647
[TBL] [Abstract][Full Text] [Related]
16. Expression of p27 and apoptosis in oral leukoplakia.
Tsuzuki H; Fujieda S; Sunaga H; Narita N; Tokuriki M; Saito H
Anticancer Res; 2003; 23(2B):1265-70. PubMed ID: 12820381
[TBL] [Abstract][Full Text] [Related]
17. LAMC2 is a predictive marker for the malignant progression of leukoplakia.
Nguyen CT; Okamura T; Morita KI; Yamaguchi S; Harada H; Miki Y; Izumo T; Kayamori K; Yamaguchi A; Sakamoto K
J Oral Pathol Med; 2017 Mar; 46(3):223-231. PubMed ID: 27529842
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 amplification in tongue and cheek squamous cell carcinoma.
Mahdey HM; Ramanathan A; Ismail SM; Abraham MT; Jamaluddin M; Zain RB
Asian Pac J Cancer Prev; 2011; 12(9):2199-204. PubMed ID: 22296356
[TBL] [Abstract][Full Text] [Related]
19. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
20. Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity.
Liu SC; Sauter ER; Clapper ML; Feldman RS; Levin L; Chen SY; Yen TJ; Ross E; Engstrom PF; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):597-603. PubMed ID: 9681528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
